1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
HCA Healthcare, Inc.

HCA Healthcare, Inc.

HCA
HCA Healthcare, Inc.US flagNew York Stock Exchange
409.20
USD
+7.14
- -
88.59BMarket Cap
HCA Healthcare, Inc.
HCA
(New York Stock Exchange)

Recent

price

409.20

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
65.74
62.28
74.49
77.76
87.8
99.51
111.97
124.58
136.13
151.68
151.82
192.33
207.45
244.67
282.43
336.59
348.68
Revenue per Share
2.83
5.17
3.62
3.54
4.46
5.34
7.8
6.33
11.04
10.36
11.06
22.77
19.44
19.74
23.04
30.2
30.57
Basic EPS, GAAP
4.13
4.73
5.22
3.95
5.4
5.92
7.81
6.89
9.3
10.18
18.85
17.62
14.21
17.65
22.56
34.25
26.8
Free Cash Flow per Basic Share
9.98
0.07
7.1
0.04
0.02
- -
- -
- -
1.42
1.63
0.45
2.04
2.25
2.49
2.76
3.02
3.05
Dividend per Share
-27.32
-18.88
-21.8
-18.81
-18.77
-19.06
-19.71
-19.44
-14.44
-8.3
1.69
-3.05
-9.98
-6.68
-10
-26.83
-30.47
Book Value per Share
-33.49
-30.88
-34.29
-32.24
-34.03
-35.94
-37.8
-40.56
-37.63
-32.73
-23.59
-34.28
-44.78
-44.13
-50.37
-72.66
-79.39
Tangible Book Value per Share
426
477
443
440
420
399
371
350
343
338
339
305
290
266
250
225
224
Basic Weighted Avg Shares
28,035
29,682
33,013
34,182
36,918
39,678
41,490
43,614
46,677
51,336
51,533
58,752
60,233
64,968
70,603
75,600
78,013
Sales/Revenue/Turnover
14.86
14.61
14.59
14.02
15.07
15.03
14.94
13.89
14.23
14.06
14.09
16.47
15.03
14.82
14.94
15.83
15.48
Operating Margin (%)
1,421
1,465
1,679
1,753
1,820
1,904
1,966
2,131
2,278
2,596
2,721
2,853
2,969
3,077
3,312
3,523
3,674
Depreciation Expense
1,207
2,465
1,605
1,556
1,875
2,129
2,890
2,216
3,787
3,505
3,754
6,956
5,643
5,242
5,760
6,784
6,840
Net Income, GAAP
29.49
20.19
30.68
32.25
31.83
31.87
28.65
37.39
17.73
20.96
19.21
21.48
20.35
20.96
21.89
20.85
20.44
Effective Tax Rate (%)
4.31
8.3
4.86
4.55
5.08
5.37
6.97
5.08
8.11
6.83
7.28
11.84
9.37
8.07
8.16
8.97
8.77
Profit Margin (%)
2,650
1,679
1,591
2,342
3,450
3,716
3,252
3,819
2,644
3,439
3,629
3,960
3,741
2,272
1,237
-567
-122
Working Capital
27,633
25,645
27,495
27,590
29,088
30,255
31,160
32,858
32,033
35,076
32,468
36,097
39,466
39,072
40,196
43,456
45,288
LT Debt
-10,794
-7,014
-8,341
-6,928
-6,498
-6,046
-5,633
-4,995
-2,918
-565
2,892
1,489
-73
1,060
555
-2,771
-3,209
Total Equity
22.31
23.35
20.77
20.17
22.07
21.64
21.88
17.27
20.59
17.41
16.38
20.3
18.24
18.16
18.41
20.45
20.55
Return on Invested Capital (%)
13.21
19.82
12.06
11.27
11.56
11.38
14.21
10.21
15.97
13.27
12.4
20.01
14.91
14.27
14.59
16.5
16.41
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
5,241
8,532
6,264
LT Borrowings
41,603
39,491
43,454
LT Finance Leases
1,853
1,822
1,834
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
225
223
218
Market Capitalization
104,859
105,311
84,982

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
15,783
16,052
17,190
Cash, Cash Equivalents & STI
1,040
940
1,013
Accounts Receivable, Net
10,867
11,324
12,281
Inventories
1,652
1,681
1,662
Total Current Liabilities
16,350
19,258
17,312
Payables & Accruals
10,130
10,726
11,048
ST Debt
5,241
8,532
6,264
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-310.46%
-470.48%
-599.28%
Free Cash Flow
16.31%
6.22%
36.41%
Net Income, GAAP
16.99%
17.39%
17.78%
Sales/Revenue/Turnover
6.72%
8.03%
7.08%
Total Cash Common Dividend
- -
63.3%
-1.59%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
17,339
17,492
17,487
18,285
70,603
2025
18,321
18,605
19,161
19,513
75,600
2026
19,109
20,230
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6.04
5.64
4.99
5.75
23.04
2025
6.63
7
7.15
8.36
30.2
2026
7.28
7.79
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.7
0.66
0.66
0.66
2.76
2025
0.74
0.72
0.72
0.72
3.02
2026
0.82
0.78
- -
- -
- -
Similar Companies
Bangkok Dusit Medical Services Public Company Limited (BDULF)
Addus HomeCare Corporation (ADUS)
Medicover AB (publ) (MCVEY)
Kindly MD, Inc. (KDLYW)
Raffles Medical Group Ltd (BSL.SI)
Pihlajalinna Oyj (PIHLIS.HE)
Business
HCA Healthcare, Inc. (NYSE: HCA) operates as one of the largest for-profit health systems in the United States, owning and managing approximately 190 hospitals and 2,400 ambulatory sites of care including surgery centers, freestanding emergency rooms, urgent care centers, diagnostic and imaging centers, walk-in clinics, and physician clinics; it provides a comprehensive range of services encompassing acute inpatient care, outpatient services, emergency services, surgical services, diagnostic imaging, rehabilitation services, cardiology, oncology, orthopedics, neurology, and advanced maternal and fetal care across 20 states and the United Kingdom. Founded in 1968 by Dr. Thomas F. Frist Sr., Dr. Thomas F. Frist Jr., and Jack C. Massey, the company is headquartered in Nashville, Tennessee, and serves approximately 44 million patient encounters annually through its integrated network focused on high-quality, convenient care for diverse patient populations including those requiring high-acuity treatments and community-based services. HCA Healthcare maintains significant market presence in key regions such as Florida with 47 hospitals and 31 surgery centers, Texas with 45 hospitals and over 600 affiliated sites, and Tennessee with 13 hospitals, while supporting medical education as the largest sponsor of graduate medical education programs in the U.S. with 56 teaching hospitals. Recent strategic developments include the rollout of the cloud-based MEDITECH Expanse electronic health record platform across all acute care facilities to enhance data insights, care coordination, and innovation; the launch of CareIntel for Perinatal in collaboration with GE HealthCare to advance maternal and fetal healthcare through AI-driven clinical insights; implementation of virtual nursing programs and digital transformation initiatives to streamline operations and improve patient outcomes; authorization of a $10 billion share repurchase program in January 2025 with ongoing executions totaling billions in recent years; and planned expansions such as a new 68-bed hospital in Clarksville, Tennessee, alongside facility enhancements in Florida and California. In April 2025, HCA divested Regional Medical Center in East San Jose, California, to Santa Clara Valley Healthcare for $150 million, reflecting selective portfolio optimization amid broader growth efforts.

Company News

Company News APIChatGPT

  • prnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA

  • globenewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. – HCA

  • zacks.com

    Can Operational Resiliency Protect HCA's Long-Term Profitability?

  • gurufocus.com

    HCA DCF Analysis: Intrinsic Value $785 vs Price $429

  • defenseworld.net

    Bank of Nova Scotia Invests $18.47 Million in HCA Healthcare, Inc. $HCA

  • defenseworld.net

    10,563 Shares in HCA Healthcare, Inc. $HCA Bought by B. Metzler seel. Sohn & Co. AG

  • defenseworld.net

    Advisors Capital Management LLC Buys Shares of 6,507 HCA Healthcare, Inc. $HCA

  • businesswire.com

    HCA Healthcare, Inc. to Present at September Conferences

  • defenseworld.net

    13,003,600 Shares in HCA Healthcare, Inc. $HCA Acquired by BlackRock Inc.

  • gurufocus.com

    Is HCA Undervalued? DCF Says Worth $785

  • defenseworld.net

    Assenagon Asset Management S.A. Sells 63,779 Shares of HCA Healthcare, Inc. $HCA

  • defenseworld.net

    Deane Retirement Strategies Inc. Invests $4.80 Million in HCA Healthcare, Inc. $HCA

  • prnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA

  • businesswire.com

    HCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group

  • benzinga.com

    Jim Cramer Looked At This 'Not Great' Uranium Stock 'For Years'

  • globenewswire.com

    HCA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating HCA Healthcare, Inc. on Behalf of HCA Stockholders and Encourages Investors to Contact the Firm

  • globenewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA

  • gurufocus.com

    HCA SHAREHOLDER ALERT: HCA Healthcare, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

  • businesswire.com

    HCA SHAREHOLDER ALERT: HCA Healthcare, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

  • prnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA